Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Daewoong Co Ltd

+ Add to Watchlist

003090:KS

51,600 KRW 1,400 2.79%

As of 02:04:00 ET on 04/17/2015.

Snapshot for Daewoong Co Ltd (003090)

Open: 50,300 Day's Range: 50,300 - 52,000 Volume: 9,289
Previous Close: 50,200 52wk Range: 36,700 - 57,000 1-Yr Rtn: +40.25%

Stock Chart for 003090

No chart data available.
  • 003090:KS 51,600
  • 1D
  • 1M
  • 1Y
50,200
Interactive 003090 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 003090

Current P/E Ratio (ttm) 18.4681
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.6720
Earnings Per Share (ttm) 2,794.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 600,025.23
Shares Outstanding (M) 11.63
30 Day Average Volume 19,775
Price/Book (mrq) 1.0216
Price/Sale (ttm) 0.4918
Dividend Indicated Gross Yield 0.97%
Cash Dividend (KRW) 500.0000
Dividend Ex-Date 12/29/2014
5 Year Dividend Growth -1.31%
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 003090

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 003090

Daewoong Co., Ltd. is a investment holding company which operates biotechnology, marketing system, and healthcare entities. The Company also invests and develops over-the-counter drugs (OTC).

Yoon Young-HwanChairman/Co-Rep DirectorYoon Jae SeungVice Chairman/Co-Rep Director
Chung Nan-YoungPresident/Co-Rep DirectorChung Jong-GeunSenior Managing Director
More Company Profile & Key Executives for 003090

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil